This inventor holds 1 USPTO granted patent. Top assignee: Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.b.h.. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: The Innovative Contributions of Erich Reichel
Introduction
Erich Reichel is a notable inventor based in Graz, Austria. He has made significant contributions to the field of medical technology, particularly in the area of lithotripsy. His innovative approach has led to advancements that enhance the effectiveness of laser treatments.
Latest Patents
Reichel holds a patent for "Laser-induced shockwave lithotripsy." This invention improves the process of laser-induced shockwave lithotripsy by concentrating pulsed laser radiation in the infrared region using an optical wave guide. The method targets a concrement surrounded by an aqueous rinsing liquid, mechanically destroying it through laser-induced breakdown of the rinsing liquid. This process generates shockwaves and cavitation, effectively breaking down the concrement. A key improvement in this method is the inclusion of metal compounds in the rinsing liquid, which reduces the energy required for breakdown. These compounds include water-soluble salts of metals from the ferrous group, magnesium, and calcium, present in concentrations not exceeding 50 mmol/l.
Career Highlights
Erich Reichel is associated with Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.b.h., where he has contributed to various innovative projects. His work has been instrumental in advancing medical technologies that improve patient outcomes.
Collaborations
Reichel has collaborated with notable colleagues, including Heinz Schmidt-Kloiber and Karl Groke. Their combined expertise has fostered a productive environment for innovation and development in their field.
Conclusion
Erich Reichel's contributions to laser-induced shockwave lithotripsy exemplify the impact of innovation in medical technology. His work continues to influence advancements that enhance treatment efficacy and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile